Literature DB >> 1917979

Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. NUC18 is not histone H2B.

M L Gaido1, J A Cidlowski.   

Abstract

Glucocorticoids stimulate apoptosis in rat thymocytes that is characterized by internucleosomal DNA degradation. We have previously identified an 18-kDa calcium-dependent nuclease whose activity is associated with this DNA degradation. The existence of this nuclease has been challenged by Alnemri and Litwack (1989) J. Biol. Chem. 264, 4104-4111, who suggest that the nuclease we observed was histone H2B. We report here a modified nuclease assay which uses [32P] DNA as a substrate that has enabled the purification and characterization of the 18-kDa nuclease (NUC18). Using Bio-Rex 70 chromatography in conjunction with this assay, we show that NUC18 can be separated from histone H2B. Enzymatically active NUC18, purified to apparent homogeneity, failed to react with two different anti-histone H2B antibodies. NUC18 was inactive in the absence of calcium and known inhibitors of apoptosis, i.e. zinc and aurintricarboxylic acid inhibit its activity. Although NUC18 activity was detected in nuclear extracts of thymocytes of both control and glucocorticoid-treated thymocytes, these activities were distinct. Gel filtration analysis revealed that NUC18 was present as a high molecular weight complex (greater than 100 kDa) in both groups of cells, whereas it also existed as a low molecular weight form in glucocorticoid-treated cells. Thus, NUC18 remains a candidate for the endonuclease responsible for the DNA degradation component of the apoptotic process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

Review 2.  A biochemical hallmark of apoptosis: internucleosomal degradation of the genome.

Authors:  M M Compton
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 3.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

4.  A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis.

Authors:  H M Schätzl; L Laszlo; D M Holtzman; J Tatzelt; S J DeArmond; R I Weiner; W C Mobley; S B Prusiner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes.

Authors:  D S Ucker; P S Obermiller; W Eckhart; J R Apgar; N A Berger; J Meyers
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

Review 6.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

7.  The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death.

Authors:  J L Taupin; Q Tian; N Kedersha; M Robertson; P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Molecular cloning and expression of a cDNA encoding an apoptotic endonuclease DNase gamma.

Authors:  D Shiokawa; S Tanuma
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin.

Authors:  H Ishikawa; M Sasaki; S Noda; Y Koga
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Localization of deoxyribonuclease I gene transcripts and protein in rat tissues and its correlation with apoptotic cell elimination.

Authors:  S Zanotti; B Polzar; H Stephan; U Doll; J Niessing; H G Mannherz
Journal:  Histochem Cell Biol       Date:  1995-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.